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http://dx.doiWe demonstrated that a Klura3D, mutant of the yeast Kluyveromyces lactis is able to produce and secrete into the
growth medium considerable amounts of orotic acid. Using yeast extractepeptoneeglucose (YPD) based media we
optimized production conditions in ﬂask and bioreactor cultures. With cells grown in YPD 5% glucose medium, the best
production in ﬂask was obtained with a 1:12.5 ratio for ﬂask: culture volume, 180 rpm, 28C and 200 mM MOPS for pH
stabilization at neutral values (initial culture pH at 8.0). The best production in a 2 L bioreactor was achieved at 500 rpm
with 1 vvm aeration, 28C and pH 7.0. Under these optimum conditions, similar rates of orotic acid production were
obtained and maximum concentration achieved after 96 h was 6.7 g/L in ﬂask and bioreactor cultures. These results
revealed an excellent reproducibility between both systems and provided evidence for the biotechnological potential of
Klura3D strain to produce orotic acid since the amounts obtained are comparable to the production in ﬂask using a
similar mutant of the industrially valuable Corynebacterium glutamicum. 2015 The Society for Biotechnology, Japan. All rights reserved.[Key words: Bioprocess optimization; Kluyveromyces lactis; KlURA3; Orotic acid; Yeast biotechnology]Kluyveromyces lactis is amongst the most studied non-conven-
tional yeasts and has been increasingly used in both fundamental
research and biotechnology industry (1,2). In this study we
demonstrate that the pyrimidine-requiring mutant of K. lactis
lacking the KlURA3 gene is able to produce and secrete into the
culture medium considerable amounts of a key intermediate from
the de novo pyrimidines biosynthetic pathway e orotic acid (Fig. 1).
Orotate salts, such as magnesium, calcium or lithium orotate, have
beenwidely explored in the pharmaceutical and nutraceutical ﬁeld.
In the chemical and biotechnological industry, orotic acid has been
used as starting material to produce pyrimidines and several other
related molecules with higher market value (3e5). To our knowl-
edge, a hypoxanthine-requiring Candida tropicalis strain and a
pyrimidine-requiring Candida albicans strain were the only yeasts
reported to accumulate orotic acid in culturemedia (6,7). C. albicans
Caura3D mutants are able to accumulate orotic acid in yeast
extractepeptoneeglucose (YPD) media only if supplemented with
acetate and Saccharomyces cerevisiae ura3Dmutants do not present
evidences for orotic acid accumulation in either media (7). Beside
the presence of a transport system that facilitates secretion of orotic
acid these evidences also suggest that speciﬁc metabolic and/or
regulatory features may play a crucial role in determining if aing author at: Instituto de Investigação e Inovação em Saúde,
o Porto, Rua Alfredo Allen s/n, 4200-135 Porto, Portugal. Tel.: þ351
ax: þ351 22 6099157.
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.org/10.1016/j.jbiosc.2015.10.008particular microorganisms with similar mutation will be able to
produce large amounts of orotic acid.
Studies on pyrimidines synthesis in K. lactis are scarce but it is
well characterized in S. cerevisiae. Analysis of both genomes in-
dicates a major difference in the step leading to the formation of
orotic acid, which is the single redox reaction in the de novo py-
rimidines biosynthesis pathway and is catalyzed by dihydroorotate
dehydrogenases (DHODases) (Fig. 1). S. cerevisiae has only one gene
for a DHODase (URA1) but the presence in K. lactis of two genes
(KlURA1 and KlURA9) coding for DHODases that belong to two
distinct families is rather unexpected (8). Similar to its S. cerevisiae
homologue, KlUra1p seems to belong to the DODHase family 1A,
which includes cytosolic enzymes that use fumarate as electron
acceptor. On the other hand, KlUra9p seems to belong to family 2,
which includes enzymes that are localized in the inner mitochon-
drial membrane and deliver electrons to quinone (8,9). Although no
functional or localization studies have been made in K. lactis, this
suggests that its de novo pyrimidine biosynthesis pathway may be
coupled to the mitochondrial respiratory chain via the KlUra9p
DHODase.
Whether it is this particular feature of the de novo pyrimidines
biosynthetic pathway or other distinctive metabolic characteristic
of K. lactis that account for the amount of orotic acid produced by
the Klura3D mutant, remains to be clariﬁed. In this study, we
explored and evaluated the potential of K. lactis Klura3D as an orotic
acid producing microorganism. Growth conditions and culture
media based on YPD were optimized for orotic acid production in
both ﬂask and bioreactor.All rights reserved.
FIG. 1. Pyrimidine biosynthetic pathway. Six enzymatic steps lead to the formation of
uridine-50-phosphate (UMP) in de novo pyrimidines biosynthesis from which all py-
rimidines nucleotides are further synthesized (black). Pyrimidines salvage pathway
rely on a set of reactions in order to reutilize pyrimidines nucleosides and bases, either
intracellular or internalized from the culture media, which can enter the pathway
directly at UMP or at later steps (gray). OMP, orotidine-50-phosphate.
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K. lactis strains Klura3D and Klura5Dmutants were generated from K. lactis
DSM 70799 wild type strain (DSMZ, Braunschweig, Germany). Klura3D was used to
generate Klura1DKlura3D, Klura9DKlura3D and Klura1DKlura9DKlura3D mutants.
Full length of the open reading frame (ORF) of KlURA3, KlURA5, KlURA1 and KlURA9
genes were removed to generate the various deletion mutants. All primers used in
this study (A1/A2 and B1/B2 sets for each gene) are mentioned in Table 1. Each ORF
with ﬂanking regions were ampliﬁed by PCR from K. lactis DSM 70799 genomic DNA
using A1/A2 set of primers and then cloned into pGEM-T Easy (Promega, Madison,
WI, USA). A fragment of this construct containing only the ﬂanking regions of
each ORF was ampliﬁed by PCR using the B1/B2 set of primers and a PvuII/EcoRVTABLE 1. Primers used in this study.
Primer Sequence (50- 30)
A1-Ura3 CACTGTCTCTTCCCCTTAATGA
A2-Ura3 TGTGTGCTTGCTTCTTTTCTTATC
B1-Ura3 GTGCAACTAATTGACGGGAGT
B2-Ura3 CAGGAAACTTAATAGAACAAATCACA
A1-Ura5 GCCTTATCAGGATCAGATGAAG
A2-Ura5 CAAAGACACATCCACAAGATTTTG
B1-Ura5 TGAACAGGTGATTAATGGCGGA
B2-Ura5 TATCACCCTCGAATCTATCTTAAC
A1-Ura1 CCGAATAGTATCTGTGACTAAGA
A2-Ura1 CTACTTCTTCAGTATTAGCCTTTC
B1-Ura1 TGTTCAGTCTTACCTTGAATGTTTAT
B2-Ura1 TTTTTCATATAGCGGTGTTTAGTATAT
A1-Ura9 AATATTGATTCGGCTTCTCGTGA
A2-Ura9 TCCAACAGAATCCCAAACCCA
B1-Ura9 AGTTGATAAAAGCAAAATACGCGG
B2-Ura9 GCTGTTACCTAATTGAAGTAAGGfragment containing loxPekanMX4eloxP from pUG6 (Euroscarf, Frankfurt,
Germany) was ligated into the open vector. Each deletion cassette was then
ampliﬁed with A1/A2 primers and used to transform the parental strain by
electroporation. The mutants were selected in YPD [1% (w/v) yeast extract, 2% (w/
v) bactopeptone, 2% (w/v) glucose] supplemented with geneticin (200 mg/L) and
correct deletion was conﬁrmed by PCR using a set of primers 400 bp upstream
A1/A2. Cre/loxP-mediated marker removal procedure (10) was used to excise
KanMX4.
Media, inoculation and growth The growth media used were YPD and YPD
5% glucose [1% (w/v) yeast extract, 2% (w/v) bactopeptone, 5% (w/v) glucose]. The
set-up for inoculation of all cultures was as follows: (i) 4C stock culture: a YPD
culture grown to 2.5 g/L d.w. was centrifuged at 3000 g for 5 min and
resuspended in 1/10 of the same culture medium, stored at 4C and used for
preparing every pre-culture; this stock culture was substituted every month but
could be used longer without any effect in the pre-culture growth behavior or
orotic acid production; (ii) pre-culture: an appropriate volume from the 4C stock
culture (20 ml per ml pre-culture) was used to inoculate YPD medium and cells
were grown for 24 h at 26C and 180 rpm to a biomass concentration of 4.0 g/L
d.w.; (iii) culture: irrespective of the growth parameter tested, culture medium
composition and ﬂask or bioreactor experiments, the equivalent to 1/10 of culture
medium volume from the pre-culture was used for inoculation.
Several growth conditions were tested in ﬂask and bioreactor and are described
in the results section and ﬁgure legends. Potassium phthalate and MOPS were ob-
tained from SigmaeAldrich. Bioreactor experiments were performed in a Biostat B2
(Sartorius, Goettingen, Germany) equipped with 405-DPAS-SC-K8S/200 pH probe
(Mettler-Toledo, Columbus, OH, USA) and InPro 6800 pO2 sensor (Mettler-Toledo).
Solutions used for pH correction were 2 M NaOH and 2 M HCl. Air supply was
controlled by an MC-10SLPM mass ﬂow controller (Alicat Scientiﬁc, Tucson, AZ,
USA). Aeration, agitation, temperature and pH were automatically controlled and
maintained constant for every culture.
Crystals characterization Diffraction data from X-ray crystallography were
collected at 293 K with a Gemini PX Ultra equipped with CuKa radiation
(l¼ 1.54184 Å). The structure was solved by direct methods using SHELXS-97 and
reﬁned with SHELXL-97 (11). Carbon, oxygen, nitrogen and potassium atoms were
reﬁned anisotropically. Hydrogen atoms were reﬁned freely with isotropic
displacement parameters. The reﬁnement converged to R (all data)¼ 5.55% and
wR2 (all data)¼ 13.09%.
The scanning electron microscopy with X-ray microanalysis (SEM/EDS) exam
was performed using a high resolution scanning electron microscope with X-Ray
Microanalysis, JEOL JSM 6301F/Oxford INCA Energy 350. Samples were coatedwith a
Au/Pd thin ﬁlm, by sputtering, using the SPI Module Sputter Coater equipment.
HPLC quantiﬁcation of orotic acid and glucose For orotic acid quantiﬁca-
tion, an Hitachi HPLC system was used and consisted of the following components:
L-7100 pump, L-7250 autosampler, PCR7250 peltier cooling rack, L-7300 Plus col-
umn oven, L-7400 UV detector and D-7000 interface module. The column was a
XBridge C18 (3.5 mm; 4.6 mm 150 mm) from Waters (Milford, MA, USA) and was
kept at 22C. Mobile phase consisted of 25 mM K2HPO4/KH2PO4 at pH 7.0 and ﬂow
rate was 0.5ml/min for a total run time of 40min. Column efﬂuent wasmonitored at
280 nm. Orotic acid standard was obtained from SigmaeAldrich.
Glucose concentrations were determined by HPLC in a Jasco chromatograph
equipped with refractive index (RI) detector (Jasco 830-RI) and a Chrompack
(300 mm 6.5 mm) column at 60C, using 5 mM H2SO4 as eluent at a ﬂow rate of
0.5 ml/min.RESULTS AND DISCUSSION
K. lactis Klura3D mutant as an orotic acid producing
microorganism YPD agar plates with fully grown Klura3D
mutant cells of K. lactis started to display two types of crystal
structures after about 1 week at 4C. One type was rather large
presenting a well deﬁned star-like structure (Fig. 2A) while the
other crystals were smaller and abundant (Fig. 2B). X-ray
crystallography analysis of both type of crystals demonstrated
that its constituent matched the structure of orotate, which was
present as a monohydrated salt (Fig. 2C and D). Orotate counter-
ion was identiﬁed as potassium by SEM/EDS examination
(Fig. S1). The presence of two morphological structures is likely a
result of distinct crystal nucleation and growth when kept at 4C.
For the matter of simplicity, despite these crystals were
composed of potassium orotate monohydrate, the molecule
produced by this mutant, either in crystal structures or dissolved,
will be further referred as orotic acid.
We did not observe this phenotype in the wild type strain or in
the triple mutant Klura1DKlura9DKlura3D, in which the step prior
FIG. 2. Large (A) and small (B) crystal structures. Scale bars represent 1 mm. (C) Crystal network of potassium orotate monohydrate determined by x-ray crystallography. In the
center of the ﬁgure is a set of overlapping orotate molecules in the same disposition as the molecular structure depicted in Fig. 2D. K in green, O in red, N in blue, C in black and H in
open circles. (D) Molecular structure of orotic acid. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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deletion (Fig.1). Also, orotic acid was not detected in themedium of
wild type and Klura1DKlura9DKlura3D cells grown in liquid cultures
(data not shown), in contrast to what was observed with Klura3D
mutants (see below). These evidences demonstrated that the
interruption of de novo pyrimidines biosynthetic pathway by de-
leting KlURA3 led to the accumulation of orotic acid generated by
the irreversible oxidative reaction catalyzed by the DHODases
(KlUra1p and KlUra9p). Due to the existence of an intermediate step
catalized by orotate phosphoribosyltransferase (KlURA5p) (Fig. 1)
the mutant Klura5D was also generated and tested. This mutant
exhibited similar phenotype to the observed in Klura3D cells, pro-
ducing equivalent amounts of orotic acid in liquid cultures under
any conditions tested. Therefore, for simplicity, only results ob-
tained with Klura3D mutants are presented. Similar orotic acid
production in Klura3D and Klura5D mutants is most likely due to a
limiting phosphoribosyl pyrophosphate (PRPP) availability (Fig. 1)
that, together with the reversible nature of the enzymatic step
catalyzed by KlUra5p, favors orotic acid accumulation upon KlURA3
deletion.
Production of orotic acid in ﬂask cultures To evaluate
orotic acid production yields, Klura3D mutant was grown in ﬂask
cultures and several growth parameters were tested. Oxygen re-
quirements of Klura3D mutant and its interference in orotic acid
production were tested in different culture: ﬂask volume ratio
conditions using 250 ml ﬂat bottom ﬂasks agitated at 180 rpm,
providing this way different levels of culture aeration (Fig. 3A).Although the different ratios tested did not affect cell growth,
major differences were observed in the rate of orotic acid
production. Production rate was negatively affected below 1:8.3
ratio (30 ml:250 ml) and was maximal with a 1:12.5 ratio
(20 ml:250 ml) that led to a concentration of about 2.2 g/L after
48 h. We also evaluated the production at higher aerations using
20 ml cultures in 250 ml bafﬂed ﬂasks agitated at 180 rpm and
250 rpm but no further improvement was observed (Fig. S2).
Therefore, aeration conditions for further experiments were set to
20 ml culture in 250 ml ﬂat bottom ﬂasks agitated at 180 rpm.
These results show that an additional oxygenation above the
levels that already allow normal cell growth is required for
optimal production rate. This is consistent with the presence of a
putative mitochondrial Klura9p that links pyrimidines pathway to
the respiratory chain and is most likely playing a major role in
the enzymatic step leading to the formation of orotic acid, in
contrast to the other DODHase KlUra1p. This hypothesis was
conﬁrmed by the analysis of orotic acid production in the double
mutants Klura1DKlura3D and Klura9DKlura3D. These mutants
exhibited similar growth rates but, whereas orotic acid
production was similar using Klura3D and Klura1DKlura3D
mutants, it was strongly and negatively affected using
Klura9DKlura3D mutant (Fig. S3). This mutant was only able to
produce 0.7 g/L of orotic acid after 48 h. Therefore, oxygen seems
to be directly linked to orotic acid production due to the
predominant or more efﬁcient activity of KlUra9p DODHase.
Using the best conditions already deﬁned, different growth
temperatures from 24C to 32C were tested (Fig. 3B). Although cell
FIG. 3. Effect of aeration (A) and temperature (B) on orotic acid production and growth in ﬂask cultures. (A) Increase in aeration was achieved by incrementally decreasing volumes
of YPD growth medium (50 ml to 10 ml) in ﬂat bottom 250 ml ﬂasks agitated at 180 rpm; growth was performed at 26C. (B) YPD cultures (20 ml) were grown at different
temperatures (24C to 32C) in 250 ml ﬂat bottom ﬂasks agitated at 180 rpm. Data represent mean values and standard deviations of duplicate experiments.
628 CARVALHO ET AL. J. BIOSCI. BIOENG.,growth was lower at 24C and 32C, orotic acid production at 24C
was only delayed during the early stage, while at 32C the
maximum amount of orotic acid produced was decreased. At 24C
speciﬁc productivity was therefore higher than at temperatures
from 26C to 30C. The lower biomass and orotic acid production at
32C is probably associated with temperature sensitivity of Klura3D
mutant at a particular growth stage (after 12 h) or with deviation of
energy or resources (glucose or other nutrients) to other mecha-
nisms or metabolic pathways required for growth at this temper-
ature. Since the best results were obtained at 26Ce30C with
minor differences in both growth and orotic acid production, 28C
was chosen as the growth temperature for further optimizations.
Under these best conditions, the initial pH (ipH) of the culture
medium dropped from 6.6 (pH of YPD medium) to 4.4 during the
ﬁrst 36 h and then remained constant (Fig. S4). To evaluate theFIG. 4. pH behavior of unbuffered and buffered cultures and its effect on orotic acid productio
7.0, 7.5 and 8.0 were used to stabilize culture pH above the values obtained with unbuffer
250 ml ﬂat bottom ﬂasks at 28C and 180 rpm. Data represent mean values and standardeffects of pH in the production process different buffering systems
were tested. For these experiments, glucose concentration was
increased from the 20 g/L used in standard YPD to 50 g/L (YPD 5%
glucose) nor only to show that the culturemedia could be improved
and a glucose increment alone was sufﬁcient to signiﬁcantly in-
crease orotic acid production but also because it would better
demonstrate the efﬁcacy of the buffering system under conditions
of stronger acidiﬁcation. Data regarding pH behavior of the cultures
and its effect on orotic acid production and cell growth are sum-
marized in Fig. 4. Cells grown in unbuffered YPD 5% glucose with an
ipH 6.6 as in previous experiments, produced 2.9 g/L after 48 h and
3.9 g/L after 72 h and culture pH dropped from 6.6 to 3.4. Optimum
pH for growth of K. lactis wild type strains is known to be 4.5e5.0
and for that reason phthalate (pKa 5.5) was used to buffer the
cultures and maintain pH values close to that range. Then and growth in ﬂask cultures. Phthalate (75 mM) at ipH 5.5 and 200 mMMOPS at ipH
ed cultures at ipH 6.6 and 8.0. Growth was performed using 20 ml YPD 5% glucose in
deviations of duplicate experiments.
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of Klura3D cells and was sufﬁcient to prevent a drop over one pH
value from an ipHs of 5.5. However, stabilizing pH with phthalate
for most of the culture period at about 4.7 did not improve orotic
acid production.
To test orotic acid production in cultures with pH stabilized at
higher values, MOPS buffer (pKa 7.2) was used. MOPS has lower
buffering capacity than phthalate and a concentration of 200 mM
was required to prevent a drop of pH higher than 1e1.5 in the
cultures tested without having a negative effect on growth (Fig. 4).
In fact, some increase in ﬁnal biomass was observed in cultures
buffered with MOPS. Under these conditions, orotic acid concen-
tration far exceeded its solubility (1.8 g/L in water at 18C) and
microscopic spike like crystals were already visible at 48 h.
Therefore, for orotic acid quantiﬁcation, concentrated NaOH was
added to a ﬁnal concentration of 250 mM to dissolve orotic acid
crystals in the samples (solubility in 1 M NaOH is 50 g/L). The re-
sults shown in Fig. 4 clearly show that stabilizing culture pH withFIG. 5. Effect of agitation (rpm)/aeration (vvm) (A), temperature (B) and pH (C) on orotic ac
experiments the following conditions were maintained constant: (A) temperature and pH re
1 vvm and pH 7.0; (C) agitation, aeration and temperature respectively at 500 rpm, 1 vvm andMOPS at values closer to 7 strongly increased orotic acid produc-
tion. Both unbuffered cultures with ipH 6.6 and ipH 8.0 acidiﬁed to
pHs below 4. On the other hand, MOPS cultures that started at ipH
8.0 maintained its pH close to 7. Whereas unbuffered cultures only
produced about 3.9 g/L after 72 h without signiﬁcant increase up to
96 h, MOPS cultures with ipH 8.0 were able to produce 5.6 g/L after
72 h and 6.7 g/L after 96 h. Culture pH is therefore critical for orotic
acid production and, due to the strong tendency of the culture to
acidify, the use of this buffer system is essential to sustain pH at
optimal values. It was not possible to test orotic acid production in
buffered cultures with pH stabilized at even higher values, either
with MOPS or other buffer with higher pKa, since ipH of the culture
would necessarily have to be increased and cell growth is affected
above pH 8. Nevertheless, taking into account the differences
observed between MOPS cultures at ipH 8.0 and ipH 7.5, a signiﬁ-
cant improvement in productionwould not be expected if pH could
be stabilized above 7.0. Moreover, as shown in the following sec-
tion, maintaining culture pH at 8.0 in a bioreactor had a negativeid production, growth and glucose consumption in bioreactor cultures. For each set of
spectively at 28.0C and pH 7.0; (B) agitation, aeration and pH respectively at 500 rpm,
28.0C. Data represent mean values and standard deviations of duplicate experiments.
630 CARVALHO ET AL. J. BIOSCI. BIOENG.,effect on the production. With respect to glucose concentration, we
observed that the increase of orotic acid production was only
relevant if glucose was increased up to 50 g/L. In a buffered culture
at ipH 8.0, an additional 25 g/L of glucose (YPD 7.5% glucose) only
generated a 0.6 g/L increment of orotic acid (Fig. S5). In conclusion,
under the conditions tested, 200 mMMOPS in YPD 5% glucose with
ipH 8.0 was considered as the most adequate buffering system for
orotic acid production in ﬂask cultures.
The results obtained from cultures buffered with phthalate and
MOPS demonstrated that Klura3D cells can grow well at any pH
from about 4.5 to 7 and that pH 7 is probably the most favorable for
speciﬁc mechanisms involved in the production or secretion of
orotic acid. Available data on orotic acid producing strains with
industrial value (12) show that a similar mutant of Corynebacterium
glutamicum, with pyrimidines pathway interrupted and no further
genetic optimization, is able to produce in ﬂask cultures 8.2 g/L of
orotic acid after 120 h. Having reached an orotic acid concentration
of 6.7 g/L at 96 h in ﬂasks, our results demonstrated the high po-
tential of K. lactis Klura3D as an orotic acid producing microor-
ganism. Orotic acid production by C. glutamicum strains was
obtained using optimized and cheap production media (12). Pro-
duction by K. lactis Klura3D using YPD based media would not be
used in industry due to its costs and full media optimization should
be performed to determine the best combinatorial composition
using general and speciﬁc cheap nutrients that should be previ-
ously identiﬁed as relevant for orotic acid production. Results
already obtained in this work strongly suggest that with an opti-
mized production media and an additional 24 h production time,
ﬁnal amounts of orotic acid above 8.2 g/L could be reached after
120 h using K. lactis Klura3D.
Production of orotic acid in bioreactor To fully assess the
value of K. lactis Klura3D strain for the biotechnology industry, the
production process was further tested in a bioreactor system. Using
the information obtained from ﬂask experiments and YPD 5%
glucose as productionmedium (1 L), several conditions of agitation,
aeration, pH and temperature were tested in a 2 L bioreactor
(Fig. 5). As for ﬂask cultures with MOPS buffer, NaOH was added to
all samples removed from cultures after 24h to dissolve orotic acid
crystals and allow its quantiﬁcation by HPLC. All results obtained in
ﬂask cultures regarding optimum conditions for orotic acid
production were conﬁrmed in the bioreactor. First, with
temperature and pH maintained constant at 28C and pH 7.0, a
minimum aeration/agitation (500 rpm/1 vvm) above the one
required for optimal growth of this mutant strain, is essential and
sufﬁcient for best orotic acid production rate and yield (Fig. 5A).
For each aeration conditions we observed that pO2 dropped to
about 80% (800 rpm/2 vvm), 40% (500 rpm/1 vvm) and 10%
(400 rpm/1 vvm) (data not shown), thus indicating culture pO2
should not drop below 40%. Second, at pH 7.0 and optimum
aeration/agitation conditions, orotic acid production was higher
at 26C and 28C, being signiﬁcantly affected at 30C (Fig. 5B).
Third, at 28C and optimum aeration/agitation conditions, best
orotic acid production was obtained at neutral pH (Fig. 5C)
indicating that optimum pH for orotic acid production would be
very close or at pH 7.0. Regarding glucose consumption, despite a
minor difference observed at 30C (Fig. 5B), the results were
similar for all other conditions tested (Fig. 5A and C). Strikingly,
the Klura3D mutant strain was still able to accumulate in the
growth media large amounts of orotic acid after glucose has been
depleted. Also, differences in orotic acid production under the
different conditions tested were mostly observed after that point.
This suggests that steps of synthesis de novo leading to orotic acid
formation may not be under an effective negative control in this
mutant, leading to a continuous production under optimum
conditions as long as substrates are available. Production inbioreactor was optimal with growth parameters set to 28C,
500 rpm, 1 vvm and pH 7.0 and the amount of orotic acid
obtained after 96 h was 6.7 g/L (Fig. 5A, B or C). Analyzing these
results together with the production obtained in ﬂasks under the
optimized conditions already deﬁned (MOPS/ipH 8.0, Fig. 4), it is
evident that the rates of production are similar and the same
maximum amount of orotic acid is reached at 96 h.
Production scale-up using K. lactis have been made and proven
useful for the biotechnology industry. In this work, we demon-
strated that the biotechnological potential of the K. lactis Klura3D as
an orotic acid producing strain is highly relevant and scaling-up
using further optimized strains and media may lead to an even
more efﬁcient and industrially competitive production process
when compared to the C. glutamicum system. The high reproduc-
ibility of orotic acid production in ﬂask and bioreactor indicates that
the ﬂask system is suitable to be used as standard for evaluating
further genetic optimization on Klura3D strain prior to bioreactor
tests. K. lactis is close related to the well studied yeast S. cerevisiae,
its genome has been fully sequenced and many speciﬁc genetic
tools have been developed. Identiﬁcation of genetic targets and
directedmutagenesis could be easily achieved and already assessed
with this YPD/MOPS ﬂask system. It could also be further and easily
adapted for screening of random mutants in high-throughput
systems. Moreover, ﬂask experiments to elaborate the composi-
tion of a production and industrial medium made of cheap and
more deﬁned constituents are expected to be replicated in biore-
actor at any stage of the development process.
Supplementary data related to this article can be found at http://
dx.doi.org/10.1016/j.jbiosc.2015.10.008.
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